1.	Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study. Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CSOM230B2412, NCT01794793
2.	Efficacy of Adjuvant Mitotane Treatment (ADIUVO) Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: EudraCT 2007-007262-38, NCT00777244
3.	LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome) Phase: Phase III Type: Screening Status: Active Age: 5 to 71 Sponsor: Other Protocol IDs: CSET2011/1748, NCT01464086
4.	Does Serum-DXM Increase Diagnostic Accuracy of the Overnight DXM Suppression Test in the Work-up of Cushing's Syndrome? Phase: Phase III Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2011/1810, NCT01504555
5.	Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer Patients Phase: Phase III Type: Educational/Counseling/Training, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492
6.	Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers Phase: Phase II, Phase I Type: Tissue collection/Repository Status: Active Age: Not specified Sponsor: Other Protocol IDs: 93-102, NCT00579163
7.	A Clinical Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BBI608-201, NCT01325441
8.	Interleukin 13 PE for Adults With Advanced Cancers Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 130046, 13-C-0046, NCT01766635
9.	MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 76,770, NCT00252174
10.	External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: IOSI-RO0402, RO0402, NCT00637637
11.	Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients Phase: Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: EudraCT 2008-000759-91, NCT00786110
12.	Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer Phase: Phase II Type: Treatment Status: Active Age: 6 months and over Sponsor: Other Protocol IDs: CDR0000066485, BC-AD-2, NCT00003453
13.	A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours Phase: Phase II Type: Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: I206, NCT01396408
14.	A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 11/106, U1111-1132-5574, NCT01676428
15.	Surgery and Heated Chemotherapy for Adrenocortical Carcinoma Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 130114, 13-C-0114, NCT01833832
16.	Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-03112, 050909, U01CA132194, CINJ-050801, 050801, 0220080281, NCT00813423
17.	Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 3 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000663520, COG-ADVL0911, ADVL0911, NCT01048892
18.	Intraperitoneal Radioimmunotherapy With 131I-8H9 for Patients With Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 1 and over Sponsor: Other Protocol IDs: 09-090, NCT01099644
19.	Study of Adrenal Gland Tumors Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Active Age: 3 to 70 Sponsor: NICHD Protocol IDs: 000160, 00-CH-0160, NCT00005927
20.	German Adrenocortical Carcinoma Registry Phase: No phase specified Type: Natural history/Epidemiology Status: Active Age: Not specified Sponsor: Other Protocol IDs: Wue-ACC-R-86-03, NCT00453674
21.	Evaluation of Side Effects of Mitotane Phase: No phase specified Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: Wue-ACC-Mitotane, NCT00568139
22.	Adrenal Tumors - Pathogenesis and Therapy Phase: No phase specified Type: Diagnostic, Treatment Status: Active Age: Any age Sponsor: Other Protocol IDs: Wue-Adrenal-Tumors-92/2002, NCT00669266
23.	International Pediatric Adrenocortical Tumor Registry Phase: No phase specified Type: Tissue collection/Repository Status: Active Age: 21 and under Sponsor: Other Protocol IDs: IPACTR, NCT00700414
24.	Anesthesia Management of Retroperitoneal Adrenalectomies Phase: No phase specified Type: Supportive care Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: retroper adrenal, NCT00894335
25.	Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms Phase: No phase specified Type: Biomarker/Laboratory analysis Status: Active Age: 7 and over Sponsor: NCI Protocol IDs: 090242, 09-C-0242, NCT01005654